Skip to main content
. 2016 Mar 14;5:e14003. doi: 10.7554/eLife.14003

Table 1.

Comparison of antimicrobial susceptibility by Salmonella Typhi lineage.

DOI: http://dx.doi.org/10.7554/eLife.14003.004

E test Non-H58 (N=13) H58 (N=65) p value*
MIC50 MIC90 GM (range) MIC50 MIC90 GM (range)
Amoxicillin 0.5 1 0.77 (0.38–38) 0.75 >256 1.43 (0.38–>256) 0.0412
Chloramphenicol 3 4 2.7 (1.5–8) 4 12 5.7 (2–>256) 0.0147
Ceftriaxone 0.06 0.06 0.06 (0.05–0.13) 0.09 0.19 0.11 (0.03–0.64) 0.0004
Gatifloxacin 0.13 0.25 0.06 (0.01–2) 0.13 2 0.21 (0.01–3) 0.1197
Nalidixic acid >256 >256 21.6 (1–>256) >256 >256 346.8 (1–>256) 0.0004
Ofloxacin 0.25 0.75 0.24 (0.03–>32) 0.5 >3232 1.09 (0.03–>32) 0.0240
Trimethoprim sulphate 0.02 0.05 0.03 (0.02–0.05) 0.05 0.32 0.09 (0.01–>32) 0.0016
Ciprofloxacin 0.13 0.75 0.11 (0.01–>32) 0.38 >32 0.80 (0.02–>32) 0.0051
Ciprofloxacin susceptibility group 0.0008#
- Susceptible 6 (46.2%) 4 (6.2%)
- Intermediate 4 (30.8%) 48 (73.8%)
- Resistant 3 (23.1%) 13 (20.0%)

*Comparisons between Salmonella Typhi lineage for MICs and ciprofloxacin susceptibility groups were based on the Wilcoxon rank sum test and Fisher’s exact test. respectively.

MIC: minimum inhibitory concentration, measured in µg/ml.

#p value for comparison of susceptible vs. intermediate/resistant combined between groups by Fisher’s exact test is 0.001.

GM: geometric mean, the upper range of the values was determined by multiplying the MIC by 2 if the result was >X (for example, >256 = 256*2 = 512).